AJP - Endocrinology and Metabolism, Vol 270, Issue 6 E919-E929, Copyright © 1996 by American Physiological Society

ARTICLES

Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27

M. A. Lee, M. Bohm, M. Paul, M. Bader, U. Ganten and D. Ganten
Max Delbruck Center for Molecular Medicine, Berlin-Buch, Germany.

Transgenic techniques represent powerful tools for the study of gene-related mechanisms of diseases such as hypertension, which results from a complex interaction between genetic and environmental factors. The renin-angiotensin system, a biochemical cascade in which renin functions as the key enzyme in the formation of the effector peptide angiotensin II, plays a major role in the regulation of blood pressure. The renin gene, therefore, represents an important candidate gene for hypertension. Because rats are more suited than mice for a number of experimental settings often employed in cardiovascular research, we modified the transgenic technique to generate the transgenic rat strain TGR(mREN2)27 harboring the murine Ren-2 gene. These transgenic rats develop fulminant hypertension at an early age despite low levels of renin in plasma and kidney. In addition, high expression of the transgene in a number of extrarenal tissues is associated with increased local formation of angiotensin II. Thus the TGR(mREN2)27 rat represents a model of hypertension with a defined genetic background. Studies on the transgenic rat may not only provide new insights into pathophysiological mechanisms of hypertension in this animal model but also offer the unique possibility to investigate the function and regulation of renin-angiotensin systems in extrarenal tissues. The aim of this review is to compile the knowledge that has been accumulated to date on this transgenic rat and to discuss possible mechanisms responsible for its hypertensive phenotype.

This article has been cited by other articles:

				V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2659 - H2668. [Abstract] [Full Text] [PDF]

				E. J. Henriksen Improvement of insulin sensitivity by antagonism of the renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R974 - R980. [Abstract] [Full Text] [PDF]

				M. H. de Borst, M. M. van Timmeren, V. S. Vaidya, R. A. de Boer, M. B. A. van Dalen, A. B. Kramer, T. A. Schuurs, J. V. Bonventre, G. Navis, and H. van Goor Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase Am J Physiol Renal Physiol, January 1, 2007; 292(1): F313 - F320. [Abstract] [Full Text] [PDF]

				J. A. Jessup, P. E. Gallagher, D. B. Averill, K. B. Brosnihan, E. A. Tallant, M. C. Chappell, and C. M. Ferrario Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2166 - H2172. [Abstract] [Full Text] [PDF]

				A. M. Lemieux, C. J. Diehl, J. A. Sloniger, and E. J. Henriksen Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats J Appl Physiol, July 1, 2005; 99(1): 357 - 362. [Abstract] [Full Text] [PDF]

				J. A. Sloniger, V. Saengsirisuwan, C. J. Diehl, B. B. Dokken, N. Lailerd, A. M. Lemieux, J. S. Kim, and E. J. Henriksen Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1074 - E1081. [Abstract] [Full Text] [PDF]

				M. C. Blendea, D. Jacobs, C. S. Stump, S. I. McFarlane, C. Ogrin, G. Bahtyiar, S. Stas, P. Kumar, Q. Sha, C. M. Ferrario, et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E353 - E359. [Abstract] [Full Text] [PDF]

				H. Ji, C. Pesce, W. Zheng, J. Kim, Y. Zhang, S. Menini, J. R. Haywood, and K. Sandberg Sex differences in renal injury and nitric oxide production in renal wrap hypertension Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H43 - H47. [Abstract] [Full Text] [PDF]

				T. R. Kinnick, E. B. Youngblood, M. P. O'Keefe, V. Saengsirisuwan, M. K. Teachey, and E. J. Henriksen Exercise Effects on Muscle Insulin Signaling and Action: Selected Contribution: Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat J Appl Physiol, August 1, 2002; 93(2): 805 - 812. [Abstract] [Full Text] [PDF]

				G. Mazzocchi, L. K. Malendowicz, A. Markowska, G. Albertin, and G. G. Nussdorfer Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1027 - E1030. [Abstract] [Full Text] [PDF]

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				M. Schinke, O. Baltatu, M. Bohm, J. Peters, W. Rascher, G. Bricca, A. Lippoldt, D. Ganten, and M. Bader Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen PNAS, March 30, 1999; 96(7): 3975 - 3980. [Abstract] [Full Text] [PDF]

				J. Zhuo, M. Ohishi, and F. A. O. Mendelsohn Roles of AT1 and AT2 Receptors in the Hypertensive Ren-2 Gene Transgenic Rat Kidney Hypertension, January 1, 1999; 33(1): 347 - 353. [Abstract] [Full Text] [PDF]

				W. R. Dunn and S. M. Gardiner Differential Alteration in Vascular Structure of Resistance Arteries Isolated From the Cerebral and Mesenteric Vascular Beds of Transgenic [(mRen-2)27], Hypertensive Rats Hypertension, May 1, 1997; 29(5): 1140 - 1147. [Abstract] [Full Text]